母体免疫与早期免疫:塑造新生儿保护机制的深度解读
本文综述母体免疫通过胎盘和母乳传递保护新生儿的机制,重点讨论IgG经FcRn转运、Fc特征及糖基化对转运效率的影响。母体疫苗接种可增加病原特异性IgG并赋予婴儿被动免疫,虽可能短暂减弱婴儿疫苗反应,但当前证据表明早期保护获益超过此影响。
要点
- 母体疫苗接种通过增加病原特异性IgG经胎盘转运,为婴儿提供被动免疫保护。
- IgG转运效率受FcRn、胎盘Fcγ受体、IgG亚类分布及Fc糖基化等因素影响。
- 母体免疫可能短暂减弱婴儿疫苗反应,但早期保护获益超过此影响。
核心结论
- 母体免疫通过胎盘IgG转运和母乳成分传递保护新生儿,虽可能短暂减弱婴儿疫苗反应,但早期保护获益超过此影响。
研究设计与样本
- 本文为综述,讨论母体免疫与早期免疫的机制及影响因素。
主要发现
- 新生儿免疫偏向耐受和Th2反应,保护主要依赖胎盘和母乳传递的母体免疫。
- 胎盘IgG转运主要由FcRn介导,并受胎盘Fcγ受体、IgG亚类分布及Fc糖基化影响。
- 母体疫苗接种增加病原特异性IgG池,为婴儿提供被动免疫。
- 传递的抗体可介导Fc依赖效应功能支持早期保护。
- 母体免疫包括母体微嵌合及母乳传递免疫细胞和介质,可能塑造新生儿免疫发育和疫苗反应。
临床怎么用
- 母体疫苗接种可保护母亲并赋予婴儿被动免疫,应作为减少早期感染负担的可扩展策略。
- 需优化母体疫苗接种时机以最大化IgG转运,并调整婴儿免疫程序以减少干扰同时维持保护。
局限性
- 需明确母体免疫的长期免疫印记。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neonatal infections remain a leading cause of morbidity and mortality worldwide, reflecting the distinctive immunological state of early life, which prioritizes tolerance and regulatory/T helper 2 (Th2)-skewed responses over robust effector immunity. Protection during this vulnerable period relies largely on maternal immunity conveyed across the placenta and through breast milk. Transplacental IgG transport is mediated primarily by the neonatal Fc receptor (FcRn) and may be influenced by placental Fc gamma (Fcγ) receptors, IgG subclass distribution and Fc features, including glycosylation. Maternal, placental and fetal factors collectively determine the efficiency and functional quality of this transfer. Maternal vaccination increases the pool of pathogen-specific IgG available for fetal transfer, protecting mothers and conferring passive immunity to infants during the first months of life. Beyond neutralization, transferred antibodies can mediate Fc-dependent effector functions that support early protection. Maternal immunity also includes cellular components, such as maternal microchimerism and the transfer of immune cells and mediators via breast milk, which may shape neonatal immune development and vaccine responsiveness. Despite its benefits, maternal immunization may transiently dampen infant vaccine responses through mechanisms including antigen masking and inhibitory Fc-mediated signalling (the blunting effect). Current evidence indicates that these transient effects are outweighed by the protection achieved in early infancy. Future priorities include defining the long-term immunological imprint of maternal immunity, optimizing maternal vaccination timing to maximize IgG transfer, and refining infant immunization schedules to minimize interference while maintaining protection. Finally, expanding maternal immunization globally is a scalable strategy to reduce the burden of early-life infections.
引用
- Portet Sulla V, Soussan S, Bizot E, et al. Maternal immunization and early-life immunity: Mechanisms shaping neonatal protection. Vaccine. 2026. PMID: 41797174. doi:10.1016/j.vaccine.2026.128423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。